Clinical Trials Browser

Interventional × Urothelial Carcinoma of the Bladder × Genitourinary × Clear all

NCT02710734 2024-12-24

Risk Enabled Therapy After Initiating Neoadjuvant Chemotherapy for Bladder Cancer (RETAIN)

Phase 2 Active not recruiting

Urothelial Carcinoma of the Bladder

NCT01520038 2019-11-26

Adjuvant Proton Therapy or IMRT for the Treatment of Bladder Cancer

Phase 1/2 Completed

2 enrolled 12 charts

Urothelial Carcinoma of the Bladder